| 臺大學術典藏 |
2021-09-04T06:12:36Z |
HBV Genotype and Clinical Outcome of Chronic Hepatitis B: Facts and Puzzles
|
Tseng T.; JIA-HORNG KAO |
| 國立臺灣大學 |
2012 |
HBV genotype B patients have more serum and intrahepatic HBsAg decline following interferon therapy than genotype C patients
|
Su, Tung-Hung; Liu, Chun-Jen; Yang, Hung-Chih; Cheng, Huei-Ru; Jeng, Yung-Ming; Liu, Chen-Hua; Tseng, Tai-Chung; Chen, Chi-Ling; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 鄭永銘; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2016 |
HBV genotype is associated with early (week 12) virologic response during TDF or TAF therapy in patients with chronic hepatitis B
|
Acharya, Subrat K.; Lee, Kwan Sik; Kao, Jia-Horng; Flisiak, Robert; Flaherty, John F.; Kim, Kyungpil; Lin, Lanjia; Gaggar, Anuj; Myers, Robert P.; Osipenko, Marina; Pianko, Stephen; Chow, Wan-Cheng; Pan, Calvin Q.; 高嘉宏 |
| 國立臺灣大學 |
2009 |
Hbv Genotypes and Chronicification of Acute Hepatitis B: More Questions Than Answers
|
林志陵; 高嘉宏; LIN, CHIH-LIN; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T07:39:49Z |
HBV genotypes and chronicification of acute hepatitis B: More questions than answers
|
Lin, C.-L.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:12:24Z |
HBV genotypes and chronicification of acute hepatitis B: More questions than answers
|
Lin C.-L.; JIA-HORNG KAO |
| 國立臺灣大學 |
2005 |
Hbv Genotypes and Outcome of Hbv Infection
|
高嘉宏; 陳定信; KAO, JIA-HORNG; CHEN, DING-SHINN |
| 國立臺灣大學 |
2005 |
HBV genotypes and outcome of HBV infection
|
高嘉宏; 陳定信; 高嘉宏 |
| 臺大學術典藏 |
2018-09-10T05:25:25Z |
HBV genotypes and outcome of HBV infection [1] (multiple letters)
|
Kao, J.-H.;Chen, D.-S.;Lok, A.S.F.; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:19:06Z |
HBV genotypes and outcome of HBV infection [1] (multiple letters)
|
JIA-HORNG KAO; Chen D.-S.; Lok A.S.F. |
| 國立臺灣大學 |
2005-01 |
HBV genotypes and outcome of HBV infection.
|
Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T06:00:28Z |
HBV genotypes: Epidemiology and implications regarding natural history
|
Kao, J.-H.;Chen, D.-S.; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:18:58Z |
HBV genotypes: Epidemiology and implications regarding natural history
|
JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2018-09-10T18:03:51Z |
HBV markers for HCC prediction: Three heads are better than two?
|
Tseng, T.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:11:01Z |
HBV markers for HCC prediction: Three heads are better than two?
|
Tseng T.-C.; JIA-HORNG KAO |
| 中國醫藥大學 |
2006-04 |
HBV reactivated post chemotherapy
|
蔡金記; 廖光福; 余承儒; 鄭庚申; 彭成元 |
| 中國醫藥大學 |
2006-04-22 |
HBV reactivated post chemotherapy
|
蔡金記(Chin-Chi Tsai); 廖光福(Kuan-Fu Liao); 余承儒(Cheng-Ju Yu); 鄭庚申(Ken-Sheng Cheng); 彭成元(Cheng-Yuan Peng) |
| 國家衛生研究院 |
2009-04-20 |
HBV replication is significantly reduced by IL-6
|
Kuo, TM;Hu, CP;Chen, YL;Hong, MH;Jeng, KS;Liang, CC;Chen, ML;Chang, C |
| 東海大學 |
2009 |
HBV replication is significantly reduced by IL-6
|
Kuo T.M., Hu C., Chen Y.L., Hong M.H., Jeng K.S., Liang C.T., Chen M.L. and Chang C.; 胡承波 |
| 臺大學術典藏 |
2021-07-03T03:33:26Z |
HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice
|
Horng J.-H.; Lin W.-H.; Wu C.-R.; Lin Y.-Y.; Wu L.-L.; Chen D.-S.; PEI-JER CHEN |
| 國立臺灣大學 |
1985 |
Hbv 母兒垂直感染δ抗原抗体檢討
|
林鶴雄; 大戶齊; 衛藤隆; 川名尚; 水野正彥; LIN, HO-HSIUNG; OHTO HITOSHI; ETOH TAKASHI; KAWANA TAKASHI; MASAHIKO MIZUNO |
| 國立臺灣大學 |
2015 |
HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
|
Peng, Cheng-Yuan; Hsieh, Tsung-Cheng; Hsieh, Tsai-Yuan; Tseng, Kuo-Chih; Lin, Chih-Lin; Su, Tung-Hung; Tseng, Tai-Chung; Lin, Hans Hsienhong; Wang, Chia-Chi; Kao, Jia-Horng; 高嘉宏 |
| 臺大學術典藏 |
2021-03-09T01:47:38Z |
HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
|
Peng C.-Y.; Hsieh T.-C.; Hsieh T.-Y.; Tseng K.-C.; Lin C.-L.; TUNG-HUNG SU; Tseng T.-C.; Lin H.H.; Wang C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T06:11:28Z |
HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
|
Peng C.-Y.; Hsieh T.-C.; Hsieh T.-Y.; Tseng K.-C.; Lin C.-L.; Su T.-H.; Tseng T.-C.; Lin H.H.; Wang C.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:44:44Z |
HBV/A and HBV/C genotype predominance among patients with chronic hepatitis B virus infection in Cebu City, Philippines
|
Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen; 陳定信; 劉振驊; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 曾岱宗;高嘉宏; Batoctoy, K.S. and Tseng, T.-C. and Kao, J.-H. and Quiza, F.E. and Garcia Sr., L.H. and Lao-Tan, J.; Batoctoy, Karen S.; Tseng, Tai-Chung; Kao, Jia-Horng; Quiza, Fidelis E.; Garcia, Lamberto H.; Lao-Tan, Judy; Cheng, Huei-Ru; JIA-HORNG KAO; Kao, Jia-Horng; Batoctoy, Karen S.; Wu, Hui-Lin; Tseng, Tai-Chung; Liu, Chen-Hua; Kao, Jia-Horng; Yang, Hung-Chih; Lao-Tan, Judy; Quiza, Fidelis E.; Su, Tung-Hung; Garcia, Lamberto H. |
